GSA CAPITAL PARTNERS LLP - IRADIMED CORP ownership

IRADIMED CORP's ticker is IRMD and the CUSIP is 46266A109. A total of 55 filers reported holding IRADIMED CORP in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
GSA CAPITAL PARTNERS LLP ownership history of IRADIMED CORP
ValueSharesWeighting
Q2 2019$231,000
-40.8%
11,301
-18.7%
0.03%
-35.0%
Q1 2019$390,000
+34.9%
13,896
+17.8%
0.04%
+21.2%
Q4 2018$289,000
-24.3%
11,796
+14.6%
0.03%
+57.1%
Q3 2018$382,000
+77.7%
10,296
+4.0%
0.02%
+75.0%
Q2 2016$215,000
-69.0%
9,902
-72.7%
0.01%
-72.7%
Q1 2016$694,000
-50.7%
36,232
-27.8%
0.04%
-36.2%
Q4 2015$1,407,000
+215.5%
50,203
+174.3%
0.07%
+213.6%
Q3 2015$446,00018,3020.02%
Other shareholders
IRADIMED CORP shareholders Q2 2019
NameSharesValueWeighting ↓
Nine Ten Capital Management LLC 783,066$30,814,0005.13%
Soleus Capital Management, L.P. 773,694$30,444,8593.15%
RK Capital 335,400$13,197,9902.90%
Capital Impact Advisors, LLC 19,390$762,9970.94%
Ranger Investment Management 205,692$8,093,9800.54%
Bares Capital Management 317,000$12,473,9500.44%
Hillsdale Investment Management Inc. 109,100$4,293,0850.37%
CORNERCAP INVESTMENT COUNSEL INC 37,007$1,456,2250.26%
Riverwater Partners LLC 6,234$245,3080.22%
RICE HALL JAMES & ASSOCIATES, LLC 72,271$2,843,8640.16%
View complete list of IRADIMED CORP shareholders